MedPath

Repaglinide

These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively.  See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997

Approved
Approval ID

d7673e22-0dbb-4395-ad60-943d249203a1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 9, 2021

Manufacturers
FDA

Rising Health, LLC

DUNS: 080500961

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Repaglinide

PRODUCT DETAILS

NDC Product Code57237-159
Application NumberANDA203820
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJuly 9, 2021
Generic NameRepaglinide

INGREDIENTS (11)

REPAGLINIDEActive
Quantity: 2 mg in 1 1
Code: 668Z8C33LU
Classification: ACTIB
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLOXAMER 188Inactive
Code: LQA7B6G8JG
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MEGLUMINEInactive
Code: 6HG8UB2MUY
Classification: IACT
POLACRILIN POTASSIUMInactive
Code: 0BZ5A00FQU
Classification: IACT

Repaglinide

PRODUCT DETAILS

NDC Product Code57237-157
Application NumberANDA203820
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJuly 9, 2021
Generic NameRepaglinide

INGREDIENTS (10)

MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLOXAMER 188Inactive
Code: LQA7B6G8JG
Classification: IACT
REPAGLINIDEActive
Quantity: 0.5 mg in 1 1
Code: 668Z8C33LU
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MEGLUMINEInactive
Code: 6HG8UB2MUY
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
POLACRILIN POTASSIUMInactive
Code: 0BZ5A00FQU
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT

Repaglinide

PRODUCT DETAILS

NDC Product Code57237-158
Application NumberANDA203820
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJuly 9, 2021
Generic NameRepaglinide

INGREDIENTS (11)

FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
REPAGLINIDEActive
Quantity: 1 mg in 1 1
Code: 668Z8C33LU
Classification: ACTIB
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MEGLUMINEInactive
Code: 6HG8UB2MUY
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLACRILIN POTASSIUMInactive
Code: 0BZ5A00FQU
Classification: IACT
POLOXAMER 188Inactive
Code: LQA7B6G8JG
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.